Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Johnson & Johnson
Explore Johnson & Johnson
Core profile pages, annual revenue records, and related research hubs for this company.
Business Model Analysis
Annual Revenue: $94.2B
Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.
The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.
Johnson & Johnson earns revenue from prescription medicines and medical technologies sold to healthcare providers, wholesalers, hospitals, and patients through health systems.
Innovative Medicine is the largest segment, generating $60.401 billion in FY2025 sales.
Johnson & Johnson serves patients, physicians, hospitals, wholesalers, healthcare systems, surgery centers, pharmacies, and government and private payers.